Clinical Trials Directory

Trials / Completed

CompletedNCT01955122

Polyp Detection With the EndoRings™: A Randomized Tandem Colonoscopy Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
126 (actual)
Sponsor
EndoAid · Industry
Sex
All
Age
40 Years – 75 Years
Healthy volunteers
Accepted

Summary

To compare the adenoma miss rate with the EndoRings™ vs. the adenoma miss rate with Standard view colonoscopy. To compare the polyp miss rate with the EndoRings™ vs. the polyp miss rate with Standard view colonoscopy.In addition, time measurements including time to cecum, time for withdrawal and overall procedure time will be analyzed and reported for each group.

Detailed description

Patients who are scheduled for screening, surveillance or diagnostic colonoscopy will be recruited to the study and randomized to one of two groups. Each enrolled subject will undergo two "back-to-back" procedures. Subjects in Group A (study group) will undergo a Standard view colonoscopy followed immediately by an EndoRings™ colonoscopy. Subjects in Group B (control group) will undergo an EndoRings™ colonoscopy followed immediately by a Standard view colonoscopy. Results from the two groups will be analyzed and compared, with primary outcome measures being adenoma miss rate and polyp miss rate. Secondary outcome measures will include withdrawal time, total procedure time and characteristics of polyps detected, including size and histological results. Subjects will be followed through a 24 hour and a 7-days telephone interview for analysis of unexpected adverse events. Clinical results will be analyzed using various statistical measures of significance. Multi-center study with up to 126 patients. Up to 126 treated patients (2 groups of 57 patients +6 drop-out patients) will be enrolled into the study.

Conditions

Interventions

TypeNameDescription
DEVICETandem ColonoscopyEach patient will undergo a double procedure: standard colonoscopy using the EndoRings™ add-on device and Standard colonoscopy (without using the EndoRings™ add-on device) in a randomized order.

Timeline

Start date
2013-07-01
Primary completion
2014-07-01
Completion
2014-07-01
First posted
2013-10-07
Last updated
2017-03-06
Results posted
2017-03-06

Locations

3 sites across 3 countries: United States, Israel, Netherlands

Source: ClinicalTrials.gov record NCT01955122. Inclusion in this directory is not an endorsement.